· For research use only. Not for human consumption.
For research use only. Not for human consumption.
Here’s something that surprises a lot of people: some peptides aren’t encoded by the main human genome. MOTS-c comes from mitochondrial DNA — which is a completely different story.
Most people learn in school that DNA lives in the cell nucleus. That’s true for most of it. But mitochondria — the structures inside cells that generate energy — carry their own separate, ancient genome. For decades, scientists thought that genome was mostly a relic. Then in 2015, a research team discovered something unexpected hiding inside it: a functional peptide that could move through the body and influence biology in ways nobody predicted.
That peptide was MOTS-c. And researchers haven’t stopped talking about it since.
TL;DR: MOTS-c is a 16-amino-acid peptide encoded not by nuclear DNA but by the mitochondrial genome — specifically within the 12S rRNA gene. It was first described in a 2015 paper in Cell Metabolism by Lee et al. Since its discovery, preclinical studies in animal models have examined its role in metabolic regulation and exercise biology. It is sold for research use only, not for human consumption.
What Is MOTS-c?
MOTS-c is a 16-amino-acid peptide — a short chain of protein building blocks — first identified and described in a landmark 2015 study published in Cell Metabolism by Lee, Zeng, and colleagues at the University of Southern California. ([Lee C et al., Cell Metabolism](https://pubmed.ncbi.nlm.nih.gov/25738459/), 2015) What makes it genuinely unusual is where the instructions to make it come from: not the nuclear genome, but the mitochondrial genome.
To understand why that matters, it helps to know what mitochondria actually are. Every cell in your body contains hundreds or thousands of them. Their main job is converting nutrients into a molecule called ATP — the universal energy currency cells run on. Think of them as tiny power stations packed inside each cell.
Here’s the twist: mitochondria have their own DNA. It’s a small, circular genome, completely separate from the DNA in the cell nucleus. Scientists have known about it for a long time. They assumed it existed mainly to encode a handful of proteins involved in energy production. MOTS-c was discovered hiding within a gene called 12S rRNA — a gene previously thought to only encode structural RNA, not a peptide at all.
The name MOTS-c stands for Mitochondrial Open Reading Frame of the 12S rRNA-c. It’s a mouthful. But the “c” is important — it distinguishes this peptide from other sequences found in the same region of mitochondrial DNA.
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial genome, specifically within the 12S ribosomal RNA gene. It was first identified in 2015 by Lee, Zeng, and colleagues at the University of Southern California, published in Cell Metabolism (PMID: 25738459). Its discovery challenged the long-held assumption that mitochondrial DNA is functionally limited to energy production components.
Why Is MOTS-c’s Mitochondrial Origin a Big Deal?
The discovery of MOTS-c helped establish an entirely new category of signaling molecules called mitokines — peptides encoded by mitochondrial DNA that can act outside the mitochondria and potentially outside the cell entirely. A 2021 review in Experimental & Molecular Medicine by Kim and colleagues described mitokines as a newly recognized class of intercellular messengers with broad implications for understanding how cells communicate under metabolic stress. ([Kim KH et al., Experimental & Molecular Medicine](https://pubmed.ncbi.nlm.nih.gov/34385700/), 2021)
That’s a big deal for a few reasons. First, it expanded what scientists thought the mitochondrial genome could do. Second, it suggested mitochondria might participate in body-wide signaling — not just local energy production. Third, it raised a question researchers are still actively investigating: if MOTS-c responds to metabolic conditions inside the cell, could it serve as a kind of early-warning signal that the body’s energy systems are under stress?
The 2015 discovery paper showed that MOTS-c could travel from muscle tissue into the bloodstream in mouse models, and even translocate into the cell nucleus under certain conditions. That’s a remarkable range of movement for a peptide originating inside a mitochondrion.
MOTS-c’s capacity to move from the mitochondria to the cell nucleus represents a potential feedback loop that researchers hadn’t previously considered — the power station communicating directly with the control room. That conceptual shift is part of what makes MOTS-c so compelling to cellular biologists.
What Has Research Found About MOTS-c?
The foundational 2015 Cell Metabolism paper by Lee et al. reported that in mouse models, administration of MOTS-c was associated with changes in glucose metabolism — specifically, researchers observed effects on insulin sensitivity and metabolic markers in animal subjects. ([Lee C et al., Cell Metabolism](https://pubmed.ncbi.nlm.nih.gov/25738459/), 2015) This was the study that put MOTS-c on the research map and has since been cited hundreds of times.
Since then, the research has branched in several directions.
Metabolic Research in Animal Models
A 2019 study in Nature Communications by Lu and colleagues investigated MOTS-c in aged mouse models, observing changes in metabolic profiles that differed between older and younger animals. ([Lu H et al., Nature Communications](https://pubmed.ncbi.nlm.nih.gov/31285426/), 2019) Researchers noted that endogenous MOTS-c levels appeared to decline with age in their mouse subjects — a finding that generated significant interest in the aging research community.
Other animal model studies have examined how MOTS-c interacts with AMPK signaling pathways. AMPK is a cellular energy sensor — it detects when ATP levels drop and triggers a cascade of cellular responses. Researchers have found that MOTS-c appears to influence this pathway in preclinical models, though the mechanisms are still being worked out.
Exercise Biology Research
One of the more surprising directions in MOTS-c research involves exercise physiology. A 2020 study in Nature Aging by Kumagai and colleagues examined blood MOTS-c levels in human subjects during and after exercise — finding that circulating MOTS-c concentrations rose in response to physical activity. ([Kumagai H et al., Nature Aging](https://pubmed.ncbi.nlm.nih.gov/33072776/), 2020) This suggests MOTS-c may be part of how the body responds to exertion at the molecular level.
What’s interesting about this finding is what it implies about the peptide’s biology. If mitochondria — the structures doing the hardest work during exercise — are producing a signaling peptide that circulates in response to that work, researchers want to understand exactly what signal is being sent and to whom.
Among mitochondrial peptides, MOTS-c consistently attracts researchers from diverse disciplines — cellular biologists, aging researchers, and exercise physiologists often reference the same core literature, which reflects how broadly the preclinical findings have resonated across fields.
A 2020 study in Nature Aging by Kumagai and colleagues measured MOTS-c concentrations in human plasma before, during, and after exercise. Researchers observed statistically significant increases in circulating MOTS-c following physical activity, suggesting the peptide may function as part of the body’s exercise-responsive signaling network. (PMID: 33072776)
Aging and Longevity Research Context
MOTS-c has attracted attention from researchers studying the biology of aging, largely because of the 2019 Nature Communications data showing age-related changes in circulating MOTS-c levels in animal models. A 2021 review in Frontiers in Physiology by Conte and Bhatt specifically discussed MOTS-c as a mitokine of interest in geroscience — the scientific study of the biology of aging. ([Conte M, Bhatt DL et al., Frontiers in Physiology](https://pubmed.ncbi.nlm.nih.gov/34108899/), 2021) The research is still preclinical, but the pattern has drawn consistent scientific interest.
How Does MOTS-c Compare to Other Mitochondrial Peptides Like SS-31?
MOTS-c and SS-31 are both studied in the context of mitochondrial biology, but they’re quite different compounds. SS-31 (also known as Elamipretide) is a synthetic, cell-permeable tetrapeptide designed to target the inner mitochondrial membrane. It was engineered specifically for that purpose. ([Szeto HH, Antioxidants & Redox Signaling](https://pubmed.ncbi.nlm.nih.gov/24443973/), 2014)
MOTS-c, by contrast, is a naturally occurring peptide that the body itself produces — encoded in mitochondrial DNA and released into circulation. SS-31 acts primarily at the mitochondrial membrane. MOTS-c travels much further, entering the cytoplasm, nucleus, and bloodstream in preclinical models.
They’re studied for different questions. SS-31 research tends to focus on mitochondrial membrane integrity and oxidative stress. MOTS-c research tends to focus on systemic metabolic signaling and intercellular communication. Both are active areas of preclinical investigation with no approved therapeutic applications as of this writing.
You can read more about SS-31 in our SS-31 research overview.
SS-31 (Elamipretide) is a synthetic, cardiolipin-targeting tetrapeptide engineered to accumulate in the inner mitochondrial membrane. MOTS-c is a naturally encoded mitochondrial peptide that circulates systemically. The two compounds represent distinct approaches to mitochondrial biology research — membrane-targeted pharmacology versus endogenous intercellular signaling — and are studied using different preclinical models. (Szeto HH, Antioxidants & Redox Signaling, PMID: 24443973)
What Researchers Need to Know About MOTS-c Quality
Peptide research depends entirely on compound integrity. A 2022 commentary in PLOS ONE on research peptide standards noted that inconsistent purity across suppliers is one of the most common sources of irreproducible results in preclinical studies, making third-party verification non-negotiable for rigorous research. ([Munson SH et al., PLOS ONE](https://pubmed.ncbi.nlm.nih.gov/35085336/), 2022) For MOTS-c specifically, this matters because the peptide’s biological activity is attributed to its precise 16-amino-acid sequence — any deviation or contamination changes what you’re actually studying.
HPLC Purity Standards
High-performance liquid chromatography (HPLC) is the standard method for measuring peptide purity. Research-grade MOTS-c should carry a purity reading above 98% on HPLC analysis. Anything lower introduces uncertainty about whether observed effects in animal models are due to MOTS-c itself or to co-eluting impurities.
Mass Spectrometry Verification
HPLC tells you how pure the sample is. Mass spectrometry (MS) tells you whether it’s the right compound. A proper COA includes MS data confirming the molecular weight matches the expected value for MOTS-c (molecular formula: C₁₀₁H₁₆₂N₂₈O₂₉, MW approximately 2174.6 Da). Both data points together give researchers a reliable picture of what they’re working with.
Third-Party Testing
The most trustworthy COAs come from independent third-party laboratories — not the supplier’s own in-house testing. Third-party testing removes any conflict of interest and provides the kind of external verification that peer-reviewed research demands.
You can review COAs for Alpha Peptides’ MOTS-c on our Certificates of Analysis page, and find full purity specifications on the MOTS-c product page.
Alpha Peptides supplies MOTS-c with third-party HPLC purity verified above 98% and mass spectrometry confirmation of molecular weight — meeting the documentation standards required for reproducible preclinical research.
Frequently Asked Questions About MOTS-c
Is MOTS-c a natural peptide?
Yes — MOTS-c is naturally encoded within the human mitochondrial genome. The body produces it endogenously. However, the MOTS-c sold for research use is synthesized in a laboratory using solid-phase peptide synthesis, not extracted from biological sources. The synthetic version is designed to replicate the identical 16-amino-acid sequence described in the original 2015 discovery paper by Lee et al. in Cell Metabolism.
What does MOTS-c stand for?
MOTS-c stands for Mitochondrial Open Reading Frame of the 12S rRNA-c. The “open reading frame” part refers to a stretch of DNA that encodes a protein or peptide. The 12S rRNA is the specific gene region within mitochondrial DNA where MOTS-c was found. The “c” distinguishes it from other peptides identified in the same region of the mitochondrial genome.
Is MOTS-c related to exercise?
Preclinical and observational research suggests a connection. A 2020 Nature Aging study by Kumagai and colleagues found that circulating MOTS-c concentrations in human plasma increased significantly during and after exercise. ([Kumagai H et al., Nature Aging](https://pubmed.ncbi.nlm.nih.gov/33072776/), 2020) Researchers hypothesize that mitochondria — heavily engaged during physical activity — may release MOTS-c as part of the body’s exercise signaling response. This is an active and evolving area of investigation.
Where can researchers find MOTS-c?
Research-grade MOTS-c should be sourced from suppliers who provide third-party COAs including HPLC purity data and mass spectrometry confirmation. Alpha Peptides carries research-grade MOTS-c verified above 98% purity by independent laboratories. Verify COA documentation before any research use — all of ours are available at alpha-peptides.com/coas/.
The Bottom Line on MOTS-c Research
MOTS-c is not just another peptide. It’s a clue that the mitochondrial genome — long considered a biological footnote — is doing something more interesting than anyone expected. The discovery that it encodes functional, circulating signaling peptides has genuinely shifted how researchers think about mitochondria.
The science is still early. We’re talking about preclinical animal models and observational human studies, not clinical trials. But the volume of research activity, the range of disciplines it’s drawn in, and the novelty of the biology all make MOTS-c one of the more scientifically compelling compounds in current peptide research.
If you’re a researcher investigating mitochondrial signaling, metabolic biology, or exercise physiology, MOTS-c is a compound worth understanding — and sourcing carefully.
Explore related peptide research: What Is SS-31? A Researcher’s Guide to the Mitochondria-Targeting Peptide
For research use only. Not for human consumption. MOTS-c is an experimental compound investigated exclusively in preclinical and laboratory research contexts. It has no FDA-approved therapeutic applications. All information on this page is provided for educational purposes relating to laboratory and preclinical research. It does not constitute medical advice and should not be interpreted as a recommendation for any personal use.
